nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxychloroquine—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—ATF1—sarcoma	0.00919	0.039	CbGpPWpGaD
Hydroxychloroquine—TLR7—MyD88 dependent cascade initiated on endosome—ATF1—sarcoma	0.00902	0.0383	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll Like Receptor 9 (TLR9) Cascade—ATF1—sarcoma	0.00871	0.037	CbGpPWpGaD
Hydroxychloroquine—TLR9—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—ATF1—sarcoma	0.00727	0.0308	CbGpPWpGaD
Hydroxychloroquine—TLR9—MyD88 dependent cascade initiated on endosome—ATF1—sarcoma	0.00713	0.0303	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—ATF1—sarcoma	0.00688	0.0292	CbGpPWpGaD
Hydroxychloroquine—TLR7—hematopoietic system—sarcoma	0.00626	0.206	CbGeAlD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—ATF1—sarcoma	0.00619	0.0263	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—IGF1R—sarcoma	0.00555	0.0235	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—IGF1R—sarcoma	0.0054	0.0229	CbGpPWpGaD
Hydroxychloroquine—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—CREB1—sarcoma	0.00498	0.0211	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—ATF1—sarcoma	0.00489	0.0208	CbGpPWpGaD
Hydroxychloroquine—TLR7—MyD88 dependent cascade initiated on endosome—CREB1—sarcoma	0.00489	0.0207	CbGpPWpGaD
Hydroxychloroquine—TLR7—uterus—sarcoma	0.00473	0.156	CbGeAlD
Hydroxychloroquine—TLR7—Toll Like Receptor 9 (TLR9) Cascade—CREB1—sarcoma	0.00472	0.02	CbGpPWpGaD
Hydroxychloroquine—TLR7—lymphoid tissue—sarcoma	0.00441	0.145	CbGeAlD
Hydroxychloroquine—TLR7—tendon—sarcoma	0.00414	0.136	CbGeAlD
Hydroxychloroquine—TLR9—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—CREB1—sarcoma	0.00394	0.0167	CbGpPWpGaD
Hydroxychloroquine—TLR9—MyD88 dependent cascade initiated on endosome—CREB1—sarcoma	0.00386	0.0164	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—CREB1—sarcoma	0.00373	0.0158	CbGpPWpGaD
Hydroxychloroquine—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—JUN—sarcoma	0.00358	0.0152	CbGpPWpGaD
Hydroxychloroquine—TLR7—MyD88 dependent cascade initiated on endosome—JUN—sarcoma	0.00352	0.0149	CbGpPWpGaD
Hydroxychloroquine—TLR7—testis—sarcoma	0.00343	0.113	CbGeAlD
Hydroxychloroquine—TLR7—Toll Like Receptor 9 (TLR9) Cascade—JUN—sarcoma	0.00339	0.0144	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—CREB1—sarcoma	0.00335	0.0142	CbGpPWpGaD
Hydroxychloroquine—TLR7—liver—sarcoma	0.00324	0.107	CbGeAlD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—JUN—sarcoma	0.00312	0.0133	CbGpPWpGaD
Hydroxychloroquine—TLR9—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—JUN—sarcoma	0.00283	0.012	CbGpPWpGaD
Hydroxychloroquine—TLR9—MyD88 dependent cascade initiated on endosome—JUN—sarcoma	0.00278	0.0118	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—JUN—sarcoma	0.00268	0.0114	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—CREB1—sarcoma	0.00265	0.0112	CbGpPWpGaD
Hydroxychloroquine—TLR7—lymph node—sarcoma	0.00249	0.0819	CbGeAlD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—JUN—sarcoma	0.00247	0.0105	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—NRAS—sarcoma	0.00247	0.0105	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—JUN—sarcoma	0.00244	0.0104	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—JUN—sarcoma	0.00241	0.0102	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—NRAS—sarcoma	0.0024	0.0102	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—NRAS—sarcoma	0.00238	0.0101	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—NRAS—sarcoma	0.00231	0.00982	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—NRAS—sarcoma	0.00231	0.00982	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—KRAS—sarcoma	0.00212	0.00901	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—PLCG1—sarcoma	0.00211	0.00896	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—KRAS—sarcoma	0.00206	0.00876	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—KRAS—sarcoma	0.00205	0.00868	CbGpPWpGaD
Hydroxychloroquine—Convulsion—Thiotepa—sarcoma	0.00202	0.00276	CcSEcCtD
Hydroxychloroquine—Aplastic anaemia—Epirubicin—sarcoma	0.00202	0.00275	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—ATF1—sarcoma	0.002	0.00851	CbGpPWpGaD
Hydroxychloroquine—Agranulocytosis—Etoposide—sarcoma	0.002	0.00273	CcSEcCtD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—KRAS—sarcoma	0.00199	0.00845	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—KRAS—sarcoma	0.00199	0.00845	CbGpPWpGaD
Hydroxychloroquine—Hepatocellular injury—Doxorubicin—sarcoma	0.00199	0.00271	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00197	0.00269	CcSEcCtD
Hydroxychloroquine—CYP2D6—Melatonin metabolism and effects—FOXO1—sarcoma	0.00195	0.00827	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—JUN—sarcoma	0.00193	0.00818	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—NRAS—sarcoma	0.00192	0.00816	CbGpPWpGaD
Hydroxychloroquine—Anaemia—Vincristine—sarcoma	0.00191	0.00261	CcSEcCtD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—JUN—sarcoma	0.00191	0.00809	CbGpPWpGaD
Hydroxychloroquine—Agitation—Vincristine—sarcoma	0.0019	0.00259	CcSEcCtD
Hydroxychloroquine—Vision blurred—Mitoxantrone—sarcoma	0.0019	0.00259	CcSEcCtD
Hydroxychloroquine—Oedema—Dactinomycin—sarcoma	0.00189	0.00258	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Thiotepa—sarcoma	0.00187	0.00255	CcSEcCtD
Hydroxychloroquine—Aplastic anaemia—Doxorubicin—sarcoma	0.00187	0.00255	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Thiotepa—sarcoma	0.00187	0.00254	CcSEcCtD
Hydroxychloroquine—Anaemia—Mitoxantrone—sarcoma	0.00186	0.00254	CcSEcCtD
Hydroxychloroquine—Vertigo—Vincristine—sarcoma	0.00186	0.00253	CcSEcCtD
Hydroxychloroquine—Leukopenia—Vincristine—sarcoma	0.00185	0.00252	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Dactinomycin—sarcoma	0.00185	0.00252	CcSEcCtD
Hydroxychloroquine—Skin disorder—Thiotepa—sarcoma	0.00185	0.00252	CcSEcCtD
Hydroxychloroquine—Erythema multiforme—Etoposide—sarcoma	0.00182	0.00248	CcSEcCtD
Hydroxychloroquine—Anorexia—Thiotepa—sarcoma	0.00182	0.00247	CcSEcCtD
Hydroxychloroquine—Leukopenia—Mitoxantrone—sarcoma	0.0018	0.00246	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-mediated signalling—HRAS—sarcoma	0.0018	0.00766	CbGpPWpGaD
Hydroxychloroquine—Anorexia—Dactinomycin—sarcoma	0.0018	0.00246	CcSEcCtD
Hydroxychloroquine—Eye disorder—Etoposide—sarcoma	0.0018	0.00245	CcSEcCtD
Hydroxychloroquine—Convulsion—Vincristine—sarcoma	0.00179	0.00244	CcSEcCtD
Hydroxychloroquine—Hepatic function abnormal—Epirubicin—sarcoma	0.00179	0.00243	CcSEcCtD
Hydroxychloroquine—Photosensitivity—Epirubicin—sarcoma	0.00178	0.00242	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-related events—HRAS—sarcoma	0.00175	0.00745	CbGpPWpGaD
Hydroxychloroquine—Convulsion—Mitoxantrone—sarcoma	0.00175	0.00238	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—HRAS—sarcoma	0.00174	0.00738	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CD34—sarcoma	0.00174	0.00737	CbGpPWpGaD
Hydroxychloroquine—Alopecia—Etoposide—sarcoma	0.0017	0.00232	CcSEcCtD
Hydroxychloroquine—Somnolence—Thiotepa—sarcoma	0.00169	0.00231	CcSEcCtD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—HRAS—sarcoma	0.00169	0.00719	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—HRAS—sarcoma	0.00169	0.00719	CbGpPWpGaD
Hydroxychloroquine—Oedema—Vincristine—sarcoma	0.00169	0.0023	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—PLCG1—sarcoma	0.00167	0.00708	CbGpPWpGaD
Hydroxychloroquine—Nervous system disorder—Vincristine—sarcoma	0.00166	0.00226	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Thiotepa—sarcoma	0.00166	0.00226	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—KRAS—sarcoma	0.00165	0.00702	CbGpPWpGaD
Hydroxychloroquine—Dermatitis exfoliative—Epirubicin—sarcoma	0.00165	0.00225	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Vincristine—sarcoma	0.00165	0.00225	CcSEcCtD
Hydroxychloroquine—Hepatic function abnormal—Doxorubicin—sarcoma	0.00165	0.00225	CcSEcCtD
Hydroxychloroquine—Oedema—Mitoxantrone—sarcoma	0.00165	0.00224	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Thiotepa—sarcoma	0.00165	0.00224	CcSEcCtD
Hydroxychloroquine—Photosensitivity—Doxorubicin—sarcoma	0.00165	0.00224	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Dactinomycin—sarcoma	0.00164	0.00224	CcSEcCtD
Hydroxychloroquine—Fatigue—Thiotepa—sarcoma	0.00164	0.00224	CcSEcCtD
Hydroxychloroquine—Dermatitis bullous—Epirubicin—sarcoma	0.00163	0.00223	CcSEcCtD
Hydroxychloroquine—Fatigue—Dactinomycin—sarcoma	0.00163	0.00222	CcSEcCtD
Hydroxychloroquine—Pain—Thiotepa—sarcoma	0.00163	0.00222	CcSEcCtD
Hydroxychloroquine—Pain—Dactinomycin—sarcoma	0.00162	0.0022	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Mitoxantrone—sarcoma	0.00161	0.00219	CcSEcCtD
Hydroxychloroquine—Anorexia—Vincristine—sarcoma	0.00161	0.00219	CcSEcCtD
Hydroxychloroquine—Cardiac failure—Epirubicin—sarcoma	0.0016	0.00218	CcSEcCtD
Hydroxychloroquine—Hypoglycaemia—Epirubicin—sarcoma	0.0016	0.00218	CcSEcCtD
Hydroxychloroquine—Skin disorder—Mitoxantrone—sarcoma	0.0016	0.00218	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—ATF1—sarcoma	0.00158	0.00673	CbGpPWpGaD
Hydroxychloroquine—Anorexia—Mitoxantrone—sarcoma	0.00157	0.00214	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Thiotepa—sarcoma	0.00156	0.00212	CcSEcCtD
Hydroxychloroquine—Anaemia—Etoposide—sarcoma	0.00155	0.00211	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Dactinomycin—sarcoma	0.00155	0.00211	CcSEcCtD
Hydroxychloroquine—Affect lability—Epirubicin—sarcoma	0.00154	0.00209	CcSEcCtD
Hydroxychloroquine—Dermatitis exfoliative—Doxorubicin—sarcoma	0.00153	0.00209	CcSEcCtD
Hydroxychloroquine—Urticaria—Thiotepa—sarcoma	0.00151	0.00206	CcSEcCtD
Hydroxychloroquine—Dermatitis bullous—Doxorubicin—sarcoma	0.00151	0.00206	CcSEcCtD
Hydroxychloroquine—Vertigo—Etoposide—sarcoma	0.00151	0.00205	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Thiotepa—sarcoma	0.00151	0.00205	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Thiotepa—sarcoma	0.00151	0.00205	CcSEcCtD
Hydroxychloroquine—Leukopenia—Etoposide—sarcoma	0.0015	0.00205	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—FOXO1—sarcoma	0.0015	0.00635	CbGpPWpGaD
Hydroxychloroquine—Abdominal pain—Dactinomycin—sarcoma	0.0015	0.00204	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Dactinomycin—sarcoma	0.0015	0.00204	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—PDGFRB—sarcoma	0.00149	0.00634	CbGpPWpGaD
Hydroxychloroquine—Hypoglycaemia—Doxorubicin—sarcoma	0.00148	0.00202	CcSEcCtD
Hydroxychloroquine—Cardiac failure—Doxorubicin—sarcoma	0.00148	0.00202	CcSEcCtD
Hydroxychloroquine—Mood swings—Epirubicin—sarcoma	0.00148	0.00201	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Etoposide—sarcoma	0.00147	0.00201	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—PDGFRA—sarcoma	0.00147	0.00624	CbGpPWpGaD
Hydroxychloroquine—Decreased appetite—Vincristine—sarcoma	0.00147	0.002	CcSEcCtD
Hydroxychloroquine—Ataxia—Epirubicin—sarcoma	0.00147	0.002	CcSEcCtD
Hydroxychloroquine—Somnolence—Mitoxantrone—sarcoma	0.00146	0.00199	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Vincristine—sarcoma	0.00146	0.00199	CcSEcCtD
Hydroxychloroquine—Fatigue—Vincristine—sarcoma	0.00146	0.00198	CcSEcCtD
Hydroxychloroquine—Convulsion—Etoposide—sarcoma	0.00145	0.00198	CcSEcCtD
Hydroxychloroquine—Pain—Vincristine—sarcoma	0.00144	0.00197	CcSEcCtD
Hydroxychloroquine—Liver function test abnormal—Epirubicin—sarcoma	0.00144	0.00196	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Mitoxantrone—sarcoma	0.00143	0.00195	CcSEcCtD
Hydroxychloroquine—Abdominal pain upper—Epirubicin—sarcoma	0.00143	0.00194	CcSEcCtD
Hydroxychloroquine—Affect lability—Doxorubicin—sarcoma	0.00142	0.00194	CcSEcCtD
Hydroxychloroquine—Fatigue—Mitoxantrone—sarcoma	0.00142	0.00193	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00142	0.00193	CcSEcCtD
Hydroxychloroquine—Pain—Mitoxantrone—sarcoma	0.00141	0.00192	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—HRAS—sarcoma	0.00141	0.00597	CbGpPWpGaD
Hydroxychloroquine—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.00141	0.00192	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Thiotepa—sarcoma	0.0014	0.00191	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Dactinomycin—sarcoma	0.00139	0.0019	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Vincristine—sarcoma	0.00138	0.00188	CcSEcCtD
Hydroxychloroquine—Muscular weakness—Epirubicin—sarcoma	0.00138	0.00188	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—CD34—sarcoma	0.00137	0.00583	CbGpPWpGaD
Hydroxychloroquine—Mood swings—Doxorubicin—sarcoma	0.00137	0.00186	CcSEcCtD
Hydroxychloroquine—Asthenia—Thiotepa—sarcoma	0.00137	0.00186	CcSEcCtD
Hydroxychloroquine—Ataxia—Doxorubicin—sarcoma	0.00136	0.00185	CcSEcCtD
Hydroxychloroquine—Asthenia—Dactinomycin—sarcoma	0.00136	0.00185	CcSEcCtD
Hydroxychloroquine—Pruritus—Thiotepa—sarcoma	0.00135	0.00184	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00135	0.00183	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Etoposide—sarcoma	0.00134	0.00183	CcSEcCtD
Hydroxychloroquine—Eosinophilia—Epirubicin—sarcoma	0.00134	0.00182	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Vincristine—sarcoma	0.00134	0.00182	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Vincristine—sarcoma	0.00134	0.00182	CcSEcCtD
Hydroxychloroquine—Liver function test abnormal—Doxorubicin—sarcoma	0.00133	0.00182	CcSEcCtD
Hydroxychloroquine—Skin disorder—Etoposide—sarcoma	0.00133	0.00181	CcSEcCtD
Hydroxychloroquine—Abdominal pain upper—Doxorubicin—sarcoma	0.00132	0.0018	CcSEcCtD
Hydroxychloroquine—Urticaria—Mitoxantrone—sarcoma	0.00131	0.00178	CcSEcCtD
Hydroxychloroquine—Anorexia—Etoposide—sarcoma	0.0013	0.00178	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Thiotepa—sarcoma	0.0013	0.00178	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Mitoxantrone—sarcoma	0.0013	0.00177	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Mitoxantrone—sarcoma	0.0013	0.00177	CcSEcCtD
Hydroxychloroquine—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.0013	0.00177	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Dactinomycin—sarcoma	0.00129	0.00176	CcSEcCtD
Hydroxychloroquine—Pancytopenia—Epirubicin—sarcoma	0.00128	0.00175	CcSEcCtD
Hydroxychloroquine—Muscular weakness—Doxorubicin—sarcoma	0.00127	0.00174	CcSEcCtD
Hydroxychloroquine—Dizziness—Thiotepa—sarcoma	0.00126	0.00172	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—PTPRC—sarcoma	0.00126	0.00533	CbGpPWpGaD
Hydroxychloroquine—Hypersensitivity—Vincristine—sarcoma	0.00124	0.0017	CcSEcCtD
Hydroxychloroquine—Eosinophilia—Doxorubicin—sarcoma	0.00124	0.00168	CcSEcCtD
Hydroxychloroquine—Photosensitivity reaction—Epirubicin—sarcoma	0.00123	0.00168	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—PLCG1—sarcoma	0.00123	0.00522	CbGpPWpGaD
Hydroxychloroquine—Weight decreased—Epirubicin—sarcoma	0.00122	0.00166	CcSEcCtD
Hydroxychloroquine—Somnolence—Etoposide—sarcoma	0.00122	0.00166	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Mitoxantrone—sarcoma	0.00121	0.00165	CcSEcCtD
Hydroxychloroquine—Asthenia—Vincristine—sarcoma	0.00121	0.00165	CcSEcCtD
Hydroxychloroquine—Vomiting—Thiotepa—sarcoma	0.00121	0.00165	CcSEcCtD
Hydroxychloroquine—Drowsiness—Epirubicin—sarcoma	0.0012	0.00164	CcSEcCtD
Hydroxychloroquine—Vomiting—Dactinomycin—sarcoma	0.0012	0.00164	CcSEcCtD
Hydroxychloroquine—Rash—Thiotepa—sarcoma	0.0012	0.00164	CcSEcCtD
Hydroxychloroquine—Dermatitis—Thiotepa—sarcoma	0.0012	0.00164	CcSEcCtD
Hydroxychloroquine—Headache—Thiotepa—sarcoma	0.00119	0.00163	CcSEcCtD
Hydroxychloroquine—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.00119	0.00162	CcSEcCtD
Hydroxychloroquine—Rash—Dactinomycin—sarcoma	0.00119	0.00162	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Etoposide—sarcoma	0.00119	0.00162	CcSEcCtD
Hydroxychloroquine—Pancytopenia—Doxorubicin—sarcoma	0.00119	0.00162	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—FOXO1—sarcoma	0.00118	0.00502	CbGpPWpGaD
Hydroxychloroquine—Gastrointestinal disorder—Etoposide—sarcoma	0.00118	0.00161	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—PDGFRB—sarcoma	0.00118	0.00501	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Mitoxantrone—sarcoma	0.00118	0.00161	CcSEcCtD
Hydroxychloroquine—Fatigue—Etoposide—sarcoma	0.00118	0.00161	CcSEcCtD
Hydroxychloroquine—Pain—Etoposide—sarcoma	0.00117	0.00159	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—ATF1—sarcoma	0.00117	0.00496	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—PDGFRA—sarcoma	0.00116	0.00494	CbGpPWpGaD
Hydroxychloroquine—Diarrhoea—Vincristine—sarcoma	0.00116	0.00158	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—KIT—sarcoma	0.00114	0.00484	CbGpPWpGaD
Hydroxychloroquine—Photosensitivity reaction—Doxorubicin—sarcoma	0.00114	0.00155	CcSEcCtD
Hydroxychloroquine—Nausea—Thiotepa—sarcoma	0.00113	0.00154	CcSEcCtD
Hydroxychloroquine—Weight decreased—Doxorubicin—sarcoma	0.00113	0.00154	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Mitoxantrone—sarcoma	0.00113	0.00153	CcSEcCtD
Hydroxychloroquine—Nausea—Dactinomycin—sarcoma	0.00112	0.00153	CcSEcCtD
Hydroxychloroquine—Agranulocytosis—Epirubicin—sarcoma	0.00112	0.00153	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Etoposide—sarcoma	0.00112	0.00152	CcSEcCtD
Hydroxychloroquine—Dizziness—Vincristine—sarcoma	0.00112	0.00152	CcSEcCtD
Hydroxychloroquine—Drowsiness—Doxorubicin—sarcoma	0.00111	0.00152	CcSEcCtD
Hydroxychloroquine—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.0011	0.0015	CcSEcCtD
Hydroxychloroquine—Urticaria—Etoposide—sarcoma	0.00109	0.00148	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—CREB1—sarcoma	0.00109	0.00461	CbGpPWpGaD
Hydroxychloroquine—Haemoglobin—Epirubicin—sarcoma	0.00109	0.00148	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Etoposide—sarcoma	0.00108	0.00147	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Etoposide—sarcoma	0.00108	0.00147	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Epirubicin—sarcoma	0.00108	0.00147	CcSEcCtD
Hydroxychloroquine—Vomiting—Vincristine—sarcoma	0.00107	0.00146	CcSEcCtD
Hydroxychloroquine—Rash—Vincristine—sarcoma	0.00107	0.00145	CcSEcCtD
Hydroxychloroquine—Dermatitis—Vincristine—sarcoma	0.00106	0.00145	CcSEcCtD
Hydroxychloroquine—Headache—Vincristine—sarcoma	0.00106	0.00144	CcSEcCtD
Hydroxychloroquine—Vomiting—Mitoxantrone—sarcoma	0.00105	0.00143	CcSEcCtD
Hydroxychloroquine—Visual impairment—Epirubicin—sarcoma	0.00104	0.00142	CcSEcCtD
Hydroxychloroquine—Agranulocytosis—Doxorubicin—sarcoma	0.00104	0.00142	CcSEcCtD
Hydroxychloroquine—Rash—Mitoxantrone—sarcoma	0.00104	0.00141	CcSEcCtD
Hydroxychloroquine—Dermatitis—Mitoxantrone—sarcoma	0.00104	0.00141	CcSEcCtD
Hydroxychloroquine—Headache—Mitoxantrone—sarcoma	0.00103	0.0014	CcSEcCtD
Hydroxychloroquine—Erythema multiforme—Epirubicin—sarcoma	0.00102	0.00139	CcSEcCtD
Hydroxychloroquine—Eye disorder—Epirubicin—sarcoma	0.00101	0.00137	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Etoposide—sarcoma	0.00101	0.00137	CcSEcCtD
Hydroxychloroquine—Tinnitus—Epirubicin—sarcoma	0.00101	0.00137	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Doxorubicin—sarcoma	0.001	0.00137	CcSEcCtD
Hydroxychloroquine—Nausea—Vincristine—sarcoma	0.001	0.00137	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Doxorubicin—sarcoma	0.000999	0.00136	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—PTPRC—sarcoma	0.000993	0.00421	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Etoposide—sarcoma	0.000982	0.00134	CcSEcCtD
Hydroxychloroquine—Nausea—Mitoxantrone—sarcoma	0.000977	0.00133	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—PLCG1—sarcoma	0.000972	0.00412	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Etoposide—sarcoma	0.000968	0.00132	CcSEcCtD
Hydroxychloroquine—Visual impairment—Doxorubicin—sarcoma	0.000963	0.00131	CcSEcCtD
Hydroxychloroquine—Alopecia—Epirubicin—sarcoma	0.000954	0.0013	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—TLE1—sarcoma	0.000947	0.00402	CbGpPWpGaD
Hydroxychloroquine—Mental disorder—Epirubicin—sarcoma	0.000946	0.00129	CcSEcCtD
Hydroxychloroquine—Erythema multiforme—Doxorubicin—sarcoma	0.000945	0.00129	CcSEcCtD
Hydroxychloroquine—Malnutrition—Epirubicin—sarcoma	0.00094	0.00128	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Etoposide—sarcoma	0.000937	0.00128	CcSEcCtD
Hydroxychloroquine—Eye disorder—Doxorubicin—sarcoma	0.000934	0.00127	CcSEcCtD
Hydroxychloroquine—Tinnitus—Doxorubicin—sarcoma	0.000932	0.00127	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—ATF1—sarcoma	0.000923	0.00392	CbGpPWpGaD
Hydroxychloroquine—Tension—Epirubicin—sarcoma	0.000923	0.00126	CcSEcCtD
Hydroxychloroquine—Nervousness—Epirubicin—sarcoma	0.000913	0.00124	CcSEcCtD
Hydroxychloroquine—Dizziness—Etoposide—sarcoma	0.000905	0.00123	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—KIT—sarcoma	0.000902	0.00383	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—MDM2—sarcoma	0.000898	0.00381	CbGpPWpGaD
Hydroxychloroquine—Vision blurred—Epirubicin—sarcoma	0.000886	0.00121	CcSEcCtD
Hydroxychloroquine—Alopecia—Doxorubicin—sarcoma	0.000883	0.0012	CcSEcCtD
Hydroxychloroquine—Mental disorder—Doxorubicin—sarcoma	0.000875	0.00119	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—FOXO1—sarcoma	0.000872	0.0037	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PDGFRB—sarcoma	0.000871	0.00369	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Etoposide—sarcoma	0.00087	0.00119	CcSEcCtD
Hydroxychloroquine—Malnutrition—Doxorubicin—sarcoma	0.00087	0.00119	CcSEcCtD
Hydroxychloroquine—Anaemia—Epirubicin—sarcoma	0.000869	0.00118	CcSEcCtD
Hydroxychloroquine—Agitation—Epirubicin—sarcoma	0.000864	0.00118	CcSEcCtD
Hydroxychloroquine—Rash—Etoposide—sarcoma	0.000863	0.00118	CcSEcCtD
Hydroxychloroquine—Dermatitis—Etoposide—sarcoma	0.000862	0.00117	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—CREB1—sarcoma	0.000858	0.00364	CbGpPWpGaD
Hydroxychloroquine—Headache—Etoposide—sarcoma	0.000857	0.00117	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—PDGFRA—sarcoma	0.000857	0.00364	CbGpPWpGaD
Hydroxychloroquine—Tension—Doxorubicin—sarcoma	0.000854	0.00116	CcSEcCtD
Hydroxychloroquine—Nervousness—Doxorubicin—sarcoma	0.000845	0.00115	CcSEcCtD
Hydroxychloroquine—Vertigo—Epirubicin—sarcoma	0.000845	0.00115	CcSEcCtD
Hydroxychloroquine—Leukopenia—Epirubicin—sarcoma	0.000842	0.00115	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Epirubicin—sarcoma	0.000826	0.00113	CcSEcCtD
Hydroxychloroquine—Vision blurred—Doxorubicin—sarcoma	0.00082	0.00112	CcSEcCtD
Hydroxychloroquine—Convulsion—Epirubicin—sarcoma	0.000815	0.00111	CcSEcCtD
Hydroxychloroquine—Nausea—Etoposide—sarcoma	0.000813	0.00111	CcSEcCtD
Hydroxychloroquine—Anaemia—Doxorubicin—sarcoma	0.000804	0.0011	CcSEcCtD
Hydroxychloroquine—CYP2D6—hematopoietic system—sarcoma	0.000803	0.0265	CbGeAlD
Hydroxychloroquine—Agitation—Doxorubicin—sarcoma	0.000799	0.00109	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—VEGFC—sarcoma	0.000799	0.00339	CbGpPWpGaD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000795	0.00108	CcSEcCtD
Hydroxychloroquine—Vertigo—Doxorubicin—sarcoma	0.000782	0.00106	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—JUN—sarcoma	0.000781	0.00331	CbGpPWpGaD
Hydroxychloroquine—Leukopenia—Doxorubicin—sarcoma	0.000779	0.00106	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—CTNNB1—sarcoma	0.000775	0.00329	CbGpPWpGaD
Hydroxychloroquine—Oedema—Epirubicin—sarcoma	0.000767	0.00105	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Doxorubicin—sarcoma	0.000765	0.00104	CcSEcCtD
Hydroxychloroquine—Convulsion—Doxorubicin—sarcoma	0.000754	0.00103	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Epirubicin—sarcoma	0.000752	0.00103	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Epirubicin—sarcoma	0.000751	0.00102	CcSEcCtD
Hydroxychloroquine—Skin disorder—Epirubicin—sarcoma	0.000745	0.00102	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000735	0.001	CcSEcCtD
Hydroxychloroquine—Anorexia—Epirubicin—sarcoma	0.000731	0.000996	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—MDM2—sarcoma	0.00071	0.00301	CbGpPWpGaD
Hydroxychloroquine—Oedema—Doxorubicin—sarcoma	0.00071	0.000967	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—SRC—sarcoma	0.000701	0.00297	CbGpPWpGaD
Hydroxychloroquine—Nervous system disorder—Doxorubicin—sarcoma	0.000696	0.000948	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Doxorubicin—sarcoma	0.000695	0.000947	CcSEcCtD
Hydroxychloroquine—Skin disorder—Doxorubicin—sarcoma	0.00069	0.000939	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—FOXO1—sarcoma	0.000689	0.00293	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PDGFRB—sarcoma	0.000688	0.00292	CbGpPWpGaD
Hydroxychloroquine—Somnolence—Epirubicin—sarcoma	0.000682	0.000929	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—PDGFRA—sarcoma	0.000677	0.00287	CbGpPWpGaD
Hydroxychloroquine—Anorexia—Doxorubicin—sarcoma	0.000677	0.000922	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—NRAS—sarcoma	0.000674	0.00286	CbGpPWpGaD
Hydroxychloroquine—Decreased appetite—Epirubicin—sarcoma	0.000667	0.000909	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—KIT—sarcoma	0.000664	0.00282	CbGpPWpGaD
Hydroxychloroquine—Gastrointestinal disorder—Epirubicin—sarcoma	0.000662	0.000902	CcSEcCtD
Hydroxychloroquine—Fatigue—Epirubicin—sarcoma	0.000662	0.000901	CcSEcCtD
Hydroxychloroquine—Pain—Epirubicin—sarcoma	0.000656	0.000894	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—FLT1—sarcoma	0.000639	0.00271	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CREB1—sarcoma	0.000632	0.00268	CbGpPWpGaD
Hydroxychloroquine—Somnolence—Doxorubicin—sarcoma	0.000631	0.00086	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—PLCG1—sarcoma	0.000628	0.00267	CbGpPWpGaD
Hydroxychloroquine—Gastrointestinal pain—Epirubicin—sarcoma	0.000627	0.000855	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—JUN—sarcoma	0.000617	0.00262	CbGpPWpGaD
Hydroxychloroquine—Decreased appetite—Doxorubicin—sarcoma	0.000617	0.000841	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—EGFR—sarcoma	0.000614	0.00261	CbGpPWpGaD
Hydroxychloroquine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000613	0.000835	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—CTNNB1—sarcoma	0.000613	0.0026	CbGpPWpGaD
Hydroxychloroquine—Fatigue—Doxorubicin—sarcoma	0.000612	0.000834	CcSEcCtD
Hydroxychloroquine—Urticaria—Epirubicin—sarcoma	0.00061	0.00083	CcSEcCtD
Hydroxychloroquine—Pain—Doxorubicin—sarcoma	0.000607	0.000827	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Epirubicin—sarcoma	0.000607	0.000826	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Epirubicin—sarcoma	0.000607	0.000826	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—CXCR4—sarcoma	0.000603	0.00256	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—ATF1—sarcoma	0.000597	0.00253	CbGpPWpGaD
Hydroxychloroquine—Gastrointestinal pain—Doxorubicin—sarcoma	0.000581	0.000791	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—KRAS—sarcoma	0.00058	0.00246	CbGpPWpGaD
Hydroxychloroquine—Hypersensitivity—Epirubicin—sarcoma	0.000565	0.00077	CcSEcCtD
Hydroxychloroquine—Urticaria—Doxorubicin—sarcoma	0.000564	0.000768	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Doxorubicin—sarcoma	0.000561	0.000765	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Doxorubicin—sarcoma	0.000561	0.000765	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—SRC—sarcoma	0.000554	0.00235	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Epirubicin—sarcoma	0.00055	0.00075	CcSEcCtD
Hydroxychloroquine—Pruritus—Epirubicin—sarcoma	0.000543	0.00074	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—NRAS—sarcoma	0.000533	0.00226	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—KIT—sarcoma	0.000525	0.00223	CbGpPWpGaD
Hydroxychloroquine—Diarrhoea—Epirubicin—sarcoma	0.000525	0.000715	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—MDM2—sarcoma	0.000523	0.00222	CbGpPWpGaD
Hydroxychloroquine—Hypersensitivity—Doxorubicin—sarcoma	0.000523	0.000713	CcSEcCtD
Hydroxychloroquine—Asthenia—Doxorubicin—sarcoma	0.000509	0.000694	CcSEcCtD
Hydroxychloroquine—Dizziness—Epirubicin—sarcoma	0.000507	0.000691	CcSEcCtD
Hydroxychloroquine—Pruritus—Doxorubicin—sarcoma	0.000502	0.000684	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—CREB1—sarcoma	0.0005	0.00212	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—HRAS—sarcoma	0.000493	0.00209	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Epirubicin—sarcoma	0.000488	0.000665	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Doxorubicin—sarcoma	0.000486	0.000662	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—EGFR—sarcoma	0.000485	0.00206	CbGpPWpGaD
Hydroxychloroquine—Rash—Epirubicin—sarcoma	0.000484	0.000659	CcSEcCtD
Hydroxychloroquine—Dermatitis—Epirubicin—sarcoma	0.000483	0.000658	CcSEcCtD
Hydroxychloroquine—Headache—Epirubicin—sarcoma	0.000481	0.000655	CcSEcCtD
Hydroxychloroquine—Dizziness—Doxorubicin—sarcoma	0.000469	0.00064	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—IGF1R—sarcoma	0.000468	0.00199	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IL2—sarcoma	0.000468	0.00198	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—KRAS—sarcoma	0.000459	0.00195	CbGpPWpGaD
Hydroxychloroquine—Nausea—Epirubicin—sarcoma	0.000456	0.000621	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—JUN—sarcoma	0.000455	0.00193	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CTNNB1—sarcoma	0.000451	0.00192	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Doxorubicin—sarcoma	0.000451	0.000615	CcSEcCtD
Hydroxychloroquine—Rash—Doxorubicin—sarcoma	0.000448	0.00061	CcSEcCtD
Hydroxychloroquine—Dermatitis—Doxorubicin—sarcoma	0.000447	0.000609	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—FOXO1—sarcoma	0.000446	0.00189	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PDGFRB—sarcoma	0.000445	0.00189	CbGpPWpGaD
Hydroxychloroquine—Headache—Doxorubicin—sarcoma	0.000445	0.000606	CcSEcCtD
Hydroxychloroquine—CYP2D6—testis—sarcoma	0.00044	0.0145	CbGeAlD
Hydroxychloroquine—TLR9—Signaling Pathways—PDGFRA—sarcoma	0.000438	0.00186	CbGpPWpGaD
Hydroxychloroquine—Nausea—Doxorubicin—sarcoma	0.000422	0.000574	CcSEcCtD
Hydroxychloroquine—CYP2D6—liver—sarcoma	0.000416	0.0137	CbGeAlD
Hydroxychloroquine—TLR9—Immune System—MDM2—sarcoma	0.000414	0.00176	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—SRC—sarcoma	0.000408	0.00173	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—NRAS—sarcoma	0.000393	0.00167	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—HRAS—sarcoma	0.00039	0.00165	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IL2—sarcoma	0.00037	0.00157	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—KDR—sarcoma	0.000369	0.00156	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—JUN—sarcoma	0.00036	0.00153	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—EGFR—sarcoma	0.000358	0.00152	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CTNNB1—sarcoma	0.000357	0.00151	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—KIT—sarcoma	0.00034	0.00144	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—KRAS—sarcoma	0.000338	0.00143	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CREB1—sarcoma	0.000323	0.00137	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—SRC—sarcoma	0.000323	0.00137	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—NRAS—sarcoma	0.00031	0.00132	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—HRAS—sarcoma	0.000287	0.00122	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—EGFR—sarcoma	0.000283	0.0012	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MDM2—sarcoma	0.000267	0.00114	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—KRAS—sarcoma	0.000267	0.00113	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IL2—sarcoma	0.000239	0.00101	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CCND1—sarcoma	0.000233	0.000989	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—JUN—sarcoma	0.000232	0.000987	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CTNNB1—sarcoma	0.000231	0.000979	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—HRAS—sarcoma	0.000227	0.000963	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—SRC—sarcoma	0.000209	0.000885	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—VEGFA—sarcoma	0.000203	0.000862	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—NRAS—sarcoma	0.000201	0.000851	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MYC—sarcoma	0.000187	0.000793	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—EGFR—sarcoma	0.000183	0.000776	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—KRAS—sarcoma	0.000173	0.000733	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—TP53—sarcoma	0.000153	0.000651	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—HRAS—sarcoma	0.000147	0.000623	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ENO2—sarcoma	0.000133	0.000565	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—HBA1—sarcoma	0.000132	0.000562	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PLCG1—sarcoma	0.000113	0.00048	CbGpPWpGaD
